Citations (95)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Tanzeel Ur Rehman & Kaitlin M. Bratlie. (2022) Improving selective targeting to cancer-associated fibroblasts by modifying liposomes with arginine based materials. Journal of Drug Targeting 30:1, pages 94-107.
Read now
Read now
Amrita Das & Nahid Ali. (2021) Nanovaccine: an emerging strategy. Expert Review of Vaccines 20:10, pages 1273-1290.
Read now
Read now
Xiaoling Xu, Zichao Zhou, Hui Li & Yun Fan. (2021) Towards customized cancer vaccines: a promising filed in personalized cancer medicine. Expert Review of Vaccines 20:5, pages 545-557.
Read now
Read now
Claudia Maria Trombetta, Serena Marchi, Ilaria Manini, Giacomo Lazzeri & Emanuele Montomoli. (2019) Challenges in the development of egg-independent vaccines for influenza. Expert Review of Vaccines 18:7, pages 737-750.
Read now
Read now
Hannah G Kelly, Stephen J Kent & Adam K Wheatley. (2019) Immunological basis for enhanced immunity of nanoparticle vaccines. Expert Review of Vaccines 18:3, pages 269-280.
Read now
Read now
John S. Tregoning, Ryan F. Russell & Ekaterina Kinnear. (2018) Adjuvanted influenza vaccines. Human Vaccines & Immunotherapeutics 14:3, pages 550-564.
Read now
Read now
Volker Vetter, Gülhan Denizer, Leonard R. Friedland, Jyothsna Krishnan & Marla Shapiro. (2018) Understanding modern-day vaccines: what you need to know. Annals of Medicine 50:2, pages 110-120.
Read now
Read now
Carl R. Alving, Zoltan Beck, Gary R. Matyas & Mangala Rao. (2016) Liposomal adjuvants for human vaccines. Expert Opinion on Drug Delivery 13:6, pages 807-816.
Read now
Read now
Enrico D'Amelio, Simonetta Salemi & Raffaele D'Amelio. (2016) Anti-Infectious Human Vaccination in Historical Perspective. International Reviews of Immunology 35:3, pages 260-290.
Read now
Read now
Claudia A Rivera, Roberto S Gómez, Rodrigo A Díaz, Pablo F Céspedes, Janyra A Espinoza, Pablo A González, Claudia A Riedel, Susan M. Bueno & Alexis M Kalergis. (2015) Novel therapies and vaccines against the human respiratory syncytial virus. Expert Opinion on Investigational Drugs 24:12, pages 1613-1630.
Read now
Read now
Fernanda Tavares Da Silva, Alberta Di Pasquale, Juan P Yarzabal & Nathalie Garçon. (2015) Safety assessment of adjuvanted vaccines: Methodological considerations. Human Vaccines & Immunotherapeutics 11:7, pages 1814-1824.
Read now
Read now
Peggy Riese, Priya Sakthivel, Stephanie Trittel & Carlos A Guzmán. (2014) Intranasal formulations: promising strategy to deliver vaccines. Expert Opinion on Drug Delivery 11:10, pages 1619-1634.
Read now
Read now
Steven G Reed. (2013) Vaccine adjuvants. Expert Review of Vaccines 12:7, pages 705-706.
Read now
Read now
Articles from other publishers (82)
Xuhan Liu, Qiuxia Min, Huiping Song, Aochun Yue, Qin Li, Qing Zhou & Wei Han. (2023) Potentiating humoral and cellular immunity using a novel hybrid polymer-lipid nanoparticle adjuvant for HBsAg-VLP vaccine. Journal of Nanobiotechnology 21:1.
Crossref
Crossref
Nian Liu, Xiangyu Xiao, Ziqiang Zhang, Chun Mao, Mimi Wan & Jian Shen. (2023) Advances in Cancer Vaccine Research. ACS Biomaterials Science & Engineering 9:11, pages 5999-6023.
Crossref
Crossref
Sivakumar S. Moni, Siddig Ibrahim Abdelwahab, Aamena Jabeen, Mohamed Eltaib Elmobark, Duaa Aqaili, Gassem Ghoal, Bassem Oraibi, Abdulla Mohammed Farasani, Ahmed Ali Jerah, Mahdi Mohammed A. Alnajai & Abdul Majeed Hamad Mohammad Alowayni. (2023) Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations. Vaccines 11:11, pages 1704.
Crossref
Crossref
Xuhan Liu, Yifan LiuXiaoyu Yang, Xinyu LuXiao-Ning XuJiancheng Zhang & Rongjun Chen. (2023) Potentiating the Immune Responses of HBsAg-VLP Vaccine Using a Polyphosphoester-Based Cationic Polymer Adjuvant. ACS Applied Materials & Interfaces 15:42, pages 48871-48881.
Crossref
Crossref
Francisco Noé Fonseca, Vanessa Haach, Franciana Volpato Bellaver, Gabrielly Bombassaro, Danielle Gava, Luciano Paulino da Silva, Lana Flavia Baron, Mayara Simonelly, Wanessa Araújo Carvalho, Rejane Schaefer & Ana Paula Bastos. (2023) Immunological profile of mice immunized with a polyvalent virosome-based influenza vaccine. Virology Journal 20:1.
Crossref
Crossref
Rocio Mellid-Carballal, Sara Gutierrez-Gutierrez, Carmen Rivas & Marcos Garcia-Fuentes. (2023) Viral protein nanoparticles (Part 1): Pharmaceutical characteristics. European Journal of Pharmaceutical Sciences 187, pages 106460.
Crossref
Crossref
Toon Stegmann, Anna-Sophia Wiekmeijer, Kitty Kwappenberg, Suzanne van Duikeren, Farien Bhoelan, Denzel Bemelman, Thomas J. M. Beenakker, Willem-Jan Krebber, Ramon Arens & Cornelis J. M. Melief. (2023) Enhanced HPV16 E6/E7+ tumor eradication via induction of tumor-specific T cells by therapeutic vaccination with virosomes presenting synthetic long peptides. Cancer Immunology, Immunotherapy 72:8, pages 2851-2864.
Crossref
Crossref
Azam Bolhassani. (2022) Lipid-Based Delivery Systems in Development of Genetic and Subunit Vaccines. Molecular Biotechnology 65:5, pages 669-698.
Crossref
Crossref
Gerrit Koopman, Mario Amacker, Toon Stegmann, Ernst J. Verschoor, Babs E. Verstrepen, Farien Bhoelan, Denzel Bemelman, Kinga P. Böszörményi, Zahra Fagrouch, Gwendoline Kiemenyi-Kayere, Daniella Mortier, Dagmar E. Verel, Henk Niphuis, Roja Fidel Acar, Ivanela Kondova, Yolanda S. Kap, Willy M. J. M. Bogers, Petra Mooij & Sylvain Fleury. (2023) A low dose of RBD and TLR7/8 agonist displayed on influenza virosome particles protects rhesus macaque against SARS-CoV-2 challenge. Scientific Reports 13:1.
Crossref
Crossref
Walid Azab. 2023. Antimicrobial Activity of Nanoparticles. Antimicrobial Activity of Nanoparticles
133
154
.
Mohammed Asadullah Jahangir, Dibyalochan Mohanty, Amarendranath Choudhury & Syed Sarim Imam. 2023. Multifunctional And Targeted Theranostic Nanomedicines. Multifunctional And Targeted Theranostic Nanomedicines
49
76
.
Hoorieh Soleimanjahi & Seyed-Mahmood Seyed-Khorrami. 2023. Cancer Nanotechnology. Cancer Nanotechnology
229
252
.
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, Shahnaz Alom, Kangkan Deka, Tutumoni Kalita, Farak Ali, Bedanta Bhattacharjee & Lalitkumar Vora. (2022) Nanoparticle-Based Delivery Systems for Vaccines. Vaccines 10:11, pages 1946.
Crossref
Crossref
Bárbara Fernandes, Rute Castro, Farien Bhoelan, Denzel Bemelman, Ricardo A. Gomes, Júlia Costa, Patrícia Gomes-Alves, Toon Stegmann, Mario Amacker, Paula M. Alves, Sylvain Fleury & António Roldão. (2022) Insect Cells for High-Yield Production of SARS-CoV-2 Spike Protein: Building a Virosome-Based COVID-19 Vaccine Candidate. Pharmaceutics 14:4, pages 854.
Crossref
Crossref
Ge Zhu, Yong-Guang Yang & Tianmeng Sun. (2022) Engineering optimal vaccination strategies: effects of physical properties of the delivery system on functions. Biomaterials Science 10:6, pages 1408-1422.
Crossref
Crossref
Ms. Shubhangi Manikpriya, Mr. Akash Shinde, Dr. Gajanan Sanap, Mr. Aniket Bankar & Mr. Shubham Girnare. (2022) Liposomes as a Novel Drug Delivery System. International Journal of Advanced Research in Science, Communication and Technology, pages 30-39.
Crossref
Crossref
Yme U. van der Velden, Marloes Grobben, Tom G. Caniels, Judith A. Burger, Meliawati Poniman, Melissa Oomen, Esther Siteur-van Rijnstra, Khadija Tejjani, Denise Guerra, Ronald Kempers, Toon Stegmann, Marit J. van Gils & Rogier W. Sanders. (2022) A SARS-CoV-2 Wuhan spike virosome vaccine induces superior neutralization breadth compared to one using the Beta spike. Scientific Reports 12:1.
Crossref
Crossref
D. S. Tretiakova & E. L. Vodovozova. (2022) Liposomes as Adjuvants and Vaccine Delivery Systems. Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology 16:1, pages 1-20.
Crossref
Crossref
Moein Masjedi, Talieh Montahaei, Zeinab Sharafi & Atefeh Jalali. (2022) Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy. Journal of Drug Delivery Science and Technology 69, pages 103184.
Crossref
Crossref
J. Tobias, E. Garner-Spitzer, M. Drinić & U. Wiedermann. (2022) Vaccination against Her-2/neu, with focus on peptide-based vaccines. ESMO Open 7:1, pages 100361.
Crossref
Crossref
Lata Sheo Bachan Upadhyay & Nikhil Kumar. 2022. Advances in Nanotechnology-Based Drug Delivery Systems. Advances in Nanotechnology-Based Drug Delivery Systems
555
584
.
Abhijeet Nayak. 2022. Microbial Engineering for Therapeutics. Microbial Engineering for Therapeutics
163
200
.
Megha K.B., Seema A. Nayar & Mohanan P.V.. (2021) Vaccine and vaccination as a part of human life: In view of COVID‐19. Biotechnology Journal 17:1.
Crossref
Crossref
Jiae Kim, Sandhya Vasan, Jerome H. Kim & Julie A. Ake. (2021) Current approaches to HIV vaccine development: a narrative review. Journal of the International AIDS Society 24:S7.
Crossref
Crossref
Sina Soleimani & Shahla Shahsavandi. (2021) Comparative Evaluation of Mx and Alum as Bio and Conventional Adjuvants in Inducing Immune Responses by Influenza DNA Vaccine. Journal of Advances in Medical and Biomedical Research 29:137, pages 331-338.
Crossref
Crossref
Guangna Liu, Motao Zhu, Xiao Zhao & Guangjun Nie. (2021) Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity. Advanced Drug Delivery Reviews 176, pages 113889.
Crossref
Crossref
Jidang Chen, Jiehuang Wang, Jipei Zhang & Hinh Ly. (2021) Advances in Development and Application of Influenza Vaccines. Frontiers in Immunology 12.
Crossref
Crossref
Niall McMullan. 2021. Molecular Biology and Biotechnology. Molecular Biology and Biotechnology
440
488
.
Qi Su, Changrong Wang, Huijuan Song, Chuangnian Zhang, Jinjian Liu, Pingsheng Huang, Yumin Zhang, Jianhuan Zhang & Weiwei Wang. (2021) Co-delivery of anionic epitope/CpG vaccine and IDO inhibitor by self-assembled cationic liposomes for combination melanoma immunotherapy. Journal of Materials Chemistry B 9:18, pages 3892-3899.
Crossref
Crossref
Davood Anvari, Fatemeh Rezaei, Alireza Ashouri, Saeed Rezaei, Hamidreza Majidiani, Abdol Sattar Pagheh, Fatemeh Rezaei, Seyyed Ali Shariatzadeh, Amir Fotovati, Abolghasem Siyadatpanah, Shirzad Gholami & Ehsan Ahmadpour. (2020)
Current situation and future prospects of
Echinococcus granulosus
vaccine candidates: A systematic review
. Transboundary and Emerging Diseases 68:3, pages 1080-1096.
Crossref
Crossref
Maryam Behzadi, Bahareh Vakili, Alireza Ebrahiminezhad & Navid Nezafat. (2021) Iron nanoparticles as novel vaccine adjuvants. European Journal of Pharmaceutical Sciences 159, pages 105718.
Crossref
Crossref
Liqi Liu, Zi Li, Jianfang Zhou, Jian Lu, Xiyan Li, Jia Liu, Ning Xiao & Dayan Wang. (2021) The effect of single amino acid substitution at position 220 in the hemagglutinin glycoprotein on avian influenza H7N9 candidate vaccine virus. Virus Genes 57:2, pages 164-171.
Crossref
Crossref
N. А. Alpatova, Zh. I. Avdeeva, S. L. Lysikova, O. V. Golovinskaya, L. A. Gayderova & V. P. Bondarev. (2021) General characteristics of adjuvants and their mechanisms of action (part 2). BIOpreparations. Prevention, Diagnosis, Treatment 21:1, pages 20-30.
Crossref
Crossref
Sabi Airouche, Vanya Beltrami, Sylvain Fleury, Thierry Batard, Véronique Bordas‐Le Floch, Toon Stegmann, Mario Amacker, Alexander Kettner & Laurent Mascarell. (2021) Bet v 1 contiguous overlapping peptides anchored to virosomes with TLR4 agonist enhance immunotherapy efficacy in mice. Clinical & Experimental Allergy 51:2, pages 339-349.
Crossref
Crossref
Zachary R. Sia, Matthew S. Miller & Jonathan F. Lovell. (2020) Engineered Nanoparticle Applications for Recombinant Influenza Vaccines. Molecular Pharmaceutics 18:2, pages 576-592.
Crossref
Crossref
Mangala Rao, Kristina K. Peachman & Carl R. Alving. 2021. Nanoparticles for Rational Vaccine Design. Nanoparticles for Rational Vaccine Design
1
28
.
Constantin N. Baxevanis, Sotirios P. Fortis, Alexandros Ardavanis & Sonia A. Perez. (2020) Exploring Essential Issues for Improving Therapeutic Cancer Vaccine Trial Design. Cancers 12:10, pages 2908.
Crossref
Crossref
Mario Amacker, Charli Smardon, Laura Mason, Jack Sorrell, Kirk Jeffery, Michael Adler, Farien Bhoelan, Olga Belova, Mark Spengler, Beena Punnamoottil, Markus Schwaller, Olivia Bonduelle, Behazine Combadière, Toon Stegmann, Andrew Naylor, Richard Johnson, Desmond Wong & Sylvain Fleury. (2020) New GMP manufacturing processes to obtain thermostable HIV-1 gp41 virosomes under solid forms for various mucosal vaccination routes. npj Vaccines 5:1.
Crossref
Crossref
Angelika Wagner & Birgit Weinberger. (2020) Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives. Frontiers in Immunology 11.
Crossref
Crossref
Marco Tamborrini, Julia Hauser, Anja Schäfer, Mario Amacker, Paola Favuzza, Kwak Kyungtak, Sylvain Fleury & Gerd Pluschke. (2020) Vaccination with virosomally formulated recombinant CyRPA elicits protective antibodies against Plasmodium falciparum parasites in preclinical in vitro and in vivo models. npj Vaccines 5:1.
Crossref
Crossref
Aneesh Thakur & Camilla Foged. 2020. Nanoengineered Biomaterials for Advanced Drug Delivery. Nanoengineered Biomaterials for Advanced Drug Delivery
603
646
.
Satyanarayan Pattnaik, Kalpana Swain, Satya Prakash Singh & Anup Kumar Sirbaiya. 2020. Nanoengineered Biomaterials for Advanced Drug Delivery. Nanoengineered Biomaterials for Advanced Drug Delivery
163
180
.
Bhupinder Kapoor, Reena Gupta, Monica Gulati, Sachin Kumar Singh, Rubiya Khursheed & Mukta Gupta. (2019) The Why, Where, Who, How, and What of the vesicular delivery systems. Advances in Colloid and Interface Science 271, pages 101985.
Crossref
Crossref
Cynthia Calzas & Christophe Chevalier. (2019) Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections. Frontiers in Immunology 10.
Crossref
Crossref
Ning Wang, Minnan Chen & Ting Wang. (2019) Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization. Journal of Controlled Release 303, pages 130-150.
Crossref
Crossref
Pamela A. Kozlowski & Anna Aldovini. (2019) Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission. Current Immunology Reviews 15:1, pages 102-122.
Crossref
Crossref
T. A. Kuznetsova, E. V. Persiyanova, T. S. Zaporozhets & N. N. Besednova. (2019) ADJUVANTS OF INFLUENZA VACCINES: NEW POSSIBILITIES OF USING SULPHATED POLYSACCHARIDES FROM MARINE BROWN ALGAE. Problems of Virology 64:1, pages 5-11.
Crossref
Crossref
Brankica Filipić & Zorica Stojić-Vukanić. (2019) Adjuvants in vaccines registered for human use. Arhiv za farmaciju 69:6, pages 406-419.
Crossref
Crossref
Anna-Mari Reid & Namrita Lall. 2019. Medicinal Plants. Medicinal Plants
187
213
.
Lien Lybaert, Karim Vermaelen, Bruno G. De Geest & Lutz Nuhn. (2018) Immunoengineering through cancer vaccines – A personalized and multi-step vaccine approach towards precise cancer immunity. Journal of Controlled Release 289, pages 125-145.
Crossref
Crossref
Tatyana A. Kuznetsova, Elena V. Persiyanova, Svetlana P. Ermakova, Maxim Yu. Khotimchenko & Natalya N. Besednova. (2018) The Sulfated Polysaccharides of Brown Algae and Products of Their Enzymatic Transformation as Potential Vaccine Adjuvants. Natural Product Communications 13:8, pages 1934578X1801300.
Crossref
Crossref
Giulietta Saletti, Thomas Gerlach & Guus F Rimmelzwaan. (2018) Influenza vaccines: ‘tailor-made’ or ‘one fits all’. Current Opinion in Immunology 53, pages 102-110.
Crossref
Crossref
Alfred Harding & Nicholas Heaton. (2018) Efforts to Improve the Seasonal Influenza Vaccine. Vaccines 6:2, pages 19.
Crossref
Crossref
Blaise Corthésy & Gilles Bioley. (2018) Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection. Frontiers in Immunology 9.
Crossref
Crossref
Zhuting Hu, Patrick A. Ott & Catherine J. Wu. (2017) Towards personalized, tumour-specific, therapeutic vaccines for cancer. Nature Reviews Immunology 18:3, pages 168-182.
Crossref
Crossref
Deep Pooja, Amrita Kadari, Hitesh Kulhari & Ramakrishna Sistla. 2018. Lipid Nanocarriers for Drug Targeting. Lipid Nanocarriers for Drug Targeting
509
528
.
Stefanie A. Krumm & Katie J. Doores. 2020. Vaccination Strategies Against Highly Variable Pathogens. Vaccination Strategies Against Highly Variable Pathogens
129
163
.
Joshua Tobias, Joanna Jasinska, Karin Baier, Michael Kundi, Nicholas Ede, Christoph Zielinski & Ursula Wiedermann. (2017) Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide. BMC Cancer 17:1.
Crossref
Crossref
Chakree Wattanasiri, Jiraporn Paha, Marisa Ponpuak, Somsak Ruchirawat & Siwarutt Boonyarattanakalin. (2017) Synthesis of synthetic mannan backbone polysaccharides found on the surface of Mycobacterium tuberculosis as a vaccine adjuvant and their immunological properties. Carbohydrate Polymers 175, pages 746-755.
Crossref
Crossref
Velasco Cimica & Jose M. Galarza. (2017) Adjuvant formulations for virus-like particle (VLP) based vaccines. Clinical Immunology 183, pages 99-108.
Crossref
Crossref
Rebecca A.M. Blom, Mario Amacker, Christian Moser, R. Maarten van Dijk, Raffaela Bonetti, Emilie Seydoux, Sean R.R. Hall, Christophe von Garnier & Fabian Blank. (2017) Virosome-bound antigen enhances DC-dependent specific CD4+ T cell stimulation, inducing a Th1 and Treg profile in vitro. Nanomedicine: Nanotechnology, Biology and Medicine 13:5, pages 1725-1737.
Crossref
Crossref
Rebecca A. M. Blom, Mario Amacker, R. Maarten van Dijk, Christian Moser, Philip A. Stumbles, Fabian Blank & Christophe von Garnier. (2017) Pulmonary Delivery of Virosome-Bound Antigen Enhances Antigen-Specific CD4+ T Cell Proliferation Compared to Liposome-Bound or Soluble Antigen. Frontiers in Immunology 8.
Crossref
Crossref
T. Barclay & N. Petrovsky. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development
127
147
.
Paula Sampaio & Célia Pais. 2017. Immunogenetics of Fungal Diseases. Immunogenetics of Fungal Diseases
207
242
.
Elizabeth H. Nardin. 2017. Malaria. Malaria
171
194
.
Anthony L. Cunningham, Nathalie Garçon, Oberdan Leo, Leonard R. Friedland, Richard Strugnell, Béatrice Laupèze, Mark Doherty & Peter Stern. (2016) Vaccine development: From concept to early clinical testing. Vaccine 34:52, pages 6655-6664.
Crossref
Crossref
Mangala Rao & Carl R. Alving. (2016) Adjuvants for HIV vaccines. Current Opinion in HIV and AIDS 11:6, pages 585-592.
Crossref
Crossref
Sharan Bobbala & Sarah Hook. (2016) Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?. Pharmaceutical Research 33:9, pages 2078-2097.
Crossref
Crossref
Bingbing Sun & Tian Xia. (2016) Nanomaterial-based vaccine adjuvants. Journal of Materials Chemistry B 4:33, pages 5496-5509.
Crossref
Crossref
J. Fleddermann, E. Diamanti, S. Azinas, M. Košutić, L. Dähne, I. Estrela-Lopis, M. Amacker, E. Donath & S. E. Moya. (2016) Virosome engineering of colloidal particles and surfaces: bioinspired fusion to supported lipid layers. Nanoscale 8:15, pages 7933-7941.
Crossref
Crossref
Yimin Wu, David L. Narum, Sylvain Fleury, Gary Jennings & Anjali Yadava. (2015) Particle-based platforms for malaria vaccines. Vaccine 33:52, pages 7518-7524.
Crossref
Crossref
Paolo Pellegrino, Emilio Clementi & Sonia Radice. (2015) On vaccine's adjuvants and autoimmunity: Current evidence and future perspectives. Autoimmunity Reviews 14:10, pages 880-888.
Crossref
Crossref
Haruka Momose, Takuo Mizukami, Madoka Kuramitsu, Kazuya Takizawa, Atsuko Masumi, Kumiko Araki, Keiko Furuhata, Kazunari Yamaguchi & Isao Hamaguchi. (2015) Establishment of a New Quality Control and Vaccine Safety Test for Influenza Vaccines and Adjuvants Using Gene Expression Profiling. PLOS ONE 10:4, pages e0124392.
Crossref
Crossref
Alberta Pasquale, Scott Preiss, Fernanda Silva & Nathalie Garçon. (2015) Vaccine Adjuvants: from 1920 to 2015 and Beyond. Vaccines 3:2, pages 320-343.
Crossref
Crossref
Heba Shawky, Amany S. Maghraby, Mohei El-Din Solliman, Mehreshan T. El-Mokadem, Mohamed M. Sherif, Azza Arafa & Mahmoud M. Bahgat. (2015) Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate. Archives of Virology 160:4, pages 945-958.
Crossref
Crossref
Lidewij Wiersma, Guus Rimmelzwaan & Rory de Vries. (2015) Developing Universal Influenza Vaccines: Hitting the Nail, Not Just on the Head. Vaccines 3:2, pages 239-262.
Crossref
Crossref
Sujin LeeMinh Trang Nguyen. (2015) Recent Advances of Vaccine Adjuvants for Infectious Diseases. Immune Network 15:2, pages 51.
Crossref
Crossref
Reto A. Schwendener. (2014) Liposomes as vaccine delivery systems: a review of the recent advances. Therapeutic Advances in Vaccines 2:6, pages 159-182.
Crossref
Crossref
A. Martinez-Lopez, P. Garcia-Valtanen, M. Ortega-Villaizan, V. Chico, E. Gomez-Casado, J.M. Coll & A. Estepa. (2014) VHSV G glycoprotein major determinants implicated in triggering the host type I IFN antiviral response as DNA vaccine molecular adjuvants. Vaccine 32:45, pages 6012-6019.
Crossref
Crossref
Jenny G.H. Low, Lawrence S. Lee, Eng Eong Ooi, Kantharaj Ethirajulu, Pauline Yeo, Alex Matter, John E. Connolly, David A.G. Skibinski, Philippe Saudan, Martin Bachmann, Brendon J. Hanson, Qingshu Lu, Sebastian Maurer-Stroh, Sam Lim & Veronica Novotny-Diermayr. (2014) Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: Results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers. Vaccine 32:39, pages 5041-5048.
Crossref
Crossref
Asghar Abdoli, Hoorieh Soleimanjahi, Masoumeh Tavassoti Kheiri, Abbas Jamali, Vahideh Mazaheri & Meghdad Abdollahpour Alitappeh. (2014) An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice. Pathogens and Disease, pages n/a-n/a.
Crossref
Crossref
Charles H. Jones, Anders P. Hakansson & Blaine A. Pfeifer. (2014) Biomaterials at the interface of nano- and micro-scale vector–cellular interactions in genetic vaccine design. J. Mater. Chem. B 2:46, pages 8053-8068.
Crossref
Crossref